Medicare Enrolled

Dr. Medhat Mikhael, M.D.

Pain Medicine · Long Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3620 ATLANTIC AVE, Long Beach, CA 90807
5625950060
In practice since 2006 (19 years)
NPI: 1558397331 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mikhael from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mikhael? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mikhael

Dr. Medhat Mikhael is a pain medicine specialist in Long Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mikhael performed 3,654 Medicare services across 331 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mikhael received a total of $182,633 from 74 pharmaceutical and/or device companies across 884 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mikhael is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 25% volume in CA $182,633 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,654
Medicare services
Top 25% in CA for pain medicine
331
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~192 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging, lower concentration 2,881 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
695 $89 $225
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
51 $1 $3
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
15 $10 $20
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $113 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$182,633
Total received (2018-2024)
Avg $26,090/year across 7 years
Top 4% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
884
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$166,807 (91.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,353 (7.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,472 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$540
2023
$13,454
2022
$14,193
2021
$39,442
2020
$26,366
2019
$43,852
2018
$44,785

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$282
Boston Scientific Corporation
$181
PAINTEQ LLC
$48
ABBVIE INC.
$30
Top 3 companies account for 94.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$103,179
BOSTON SCIENTIFIC CORPORATION
$19,882
AbbVie Inc.
$14,915
Medtronic USA, Inc.
$10,218
Mallinckrodt LLC
$7,867
ABBVIE INC.
$6,404
Nevro Corp.
$3,039
US WorldMeds, LLC
$2,346
Allergan, Inc.
$2,328
Abbott Laboratories
$2,183
Medtronic, Inc.
$1,716
INSYS Therapeutics Inc
$1,472
Vertiflex, Inc.
$609
Assertio Therapeutics, Inc.
$588
Forte Bio-Pharma LLC
$568
PFIZER INC.
$340
Collegium Pharmaceutical, Inc.
$333
Amgen Inc.
$278
SCILEX PHARMACEUTICALS INC.
$237
Allergan Inc.
$236
West Therapeutics Development, LLC
$209
Egalet US Inc
$199
Piramal Critical Care
$182
Stimwave Technologies Incorporated
$180
Kaleo, Inc.
$159
BioDelivery Sciences International, Inc.
$158
Almatica Pharma LLC
$150
Flexion Therapeutics, Inc.
$147
AcelRx Pharmaceuticals, Inc.
$144
Stryker Corporation
$130
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$126
FIDIA PHARMA USA INC.
$121
Novartis Pharmaceuticals Corporation
$121
Lilly USA, LLC
$117
Nalu Medical, Inc.
$115
GRT US Holding, Inc.
$115
Mallinckrodt Enterprises LLC
$111
PAINTEQ LLC
$98
Pacira Therapeutics, Inc.
$85
Spinal Simplicity, LLC
$81
Biohaven Pharmaceutical Holding Company Ltd.
$75
Jazz Pharmaceuticals Inc.
$74
DePuy Synthes Sales Inc.
$74
Relievant Medsystems, Inc.
$74
Teva Pharmaceuticals USA, Inc.
$63
Biohaven Pharmaceuticals, Inc.
$61
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$57
Scilex Pharmaceuticals Inc.
$42
Daiichi Sankyo Inc.
$42
RedHill Biopharma Inc.
$39
Curonix LLC
$38
Vertos Medical, Inc.
$38
USWM, LLC
$36
TerSera Therapeutics LLC
$36
IBSA Pharma Inc.
$34
Trevena, Inc.
$31
ARBOR PHARMACEUTICALS, INC.
$30
BioMarin Pharmaceutical Inc.
$27
Arbor Pharmaceuticals, Inc.
$27
Averitas Pharma Inc.
$24
BAXTER HEALTHCARE
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Xeris Pharmaceuticals, Inc.
$20
SI-BONE, Inc.
$20
Pacira Pharmaceuticals Incorporated
$19
Hikma Pharmaceuticals USA
$16
Horizon Pharma plc
$15
Avanos Medical
$14
Zyla Life Sciences
$14
SPR Therapeutics, Inc
$13
FORTE BIO-PHARMA LLC
$13
Purdue Pharma L.P.
$13
ASSERTIO THERAPEUTICS, Inc.
$12
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 75.5% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · AQUAMANTYS · ARYMO ER · Aimovig · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · COOLIEF* COOLED RADIOFREQUENCY · Cambia · DSUVIA · DUEXIS · EMGALITY · ETERNA · EVZIO · EXPAREL · Evzio · FLECTOR · FLOSEAL · GABLOFEN · GABLOFEN 1 mL in 1 SYRINGE · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GLASS · GRALISE · General Pain Management · General - Pain Management · General - Therapies · Gralise · HA MINUTEMAN G3-R · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · Intracept · KAPSPARGO · KEVEYIS · Kloxxado · LUCEMYRA · LYRICA · Lazanda · Licart · Lucemyra · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Movantik · N'VISION · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · NuDyn · Nucynta · OFIRMEV · OLINVYK · ORTHOVISC · Olinvyk · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRECISION · PROCLAIM · PROLATE · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · QUTENZA · Qutenza · RELISTOR · RESTORE · REYVOW · SPECTRA WAVEWRITER · SPINEJACK · SPRINT PNS System · SPRIX · SUBSYS · SUPERION · SYMPROIC · SYNCHROMED · SYNCHROMEDII · SYNDROS · Senza · Senza Spinal Cord Stimulation System · Spectra WaveWriter · Subsys · Superion · Superion ISS · Superion Indirect Decompression System · THERAPIES · UBRELVY · VANTA ADAPTIVESTIM · VECTRIS · Vanta · Vimizim · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZIMHI · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pain medicine in CA.

Looking for a pain medicine specialist in Long Beach?
Compare pain medicines in the Long Beach area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
45
Per 100K population
0.5
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mikhael is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mikhael experienced with contrast dye for imaging, lower concentration?
Based on Medicare claims data, Dr. Mikhael performed 2,881 contrast dye for imaging, lower concentration services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mikhael receive payments from pharmaceutical companies?
Yes. Dr. Mikhael received a total of $182,633 from 74 companies across 884 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mikhael's costs compare to other pain medicines in Long Beach?
Dr. Mikhael's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mikhael) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →